Gene Reprogramming Has Become Possible

October 2011
USA Today Magazine;Oct2011, Vol. 140 Issue 2797, p7
The article focuses on a study by scientists from the Morganridge Institute for Research at the University of Wisconsin which shows that potentially cancer-causing mutations in induced pluripotent stem cells (IPSCs) do not exhibit substantial increases during gene reprogramming.


Related Articles

  • Opportunities and challenges of pluripotent stem cell neurodegenerative disease models. Sandoe, Jackson; Eggan, Kevin // Nature Neuroscience;Jul2013, Vol. 16 Issue 7, p780 

    Human neurodegenerative disorders are among the most difficult to study. In particular, the inability to readily obtain the faulty cell types most relevant to these diseases has impeded progress for decades. Recent advances in pluripotent stem cell technology now grant access to substantial...

  • Induced pluripotent stem cell models of Zellweger spectrum disorder show impaired peroxisome assembly and cell type-specific lipid abnormalities. Xiao-Ming Wang; Wing Yan Yik; Peilin Zhang; Wange Lu; Ning Huang; Bo Ram Kim; Shibata, Darryl; Zitting, Madison; Chow, Robert H.; Moser, Ann B.; Steinberg, Steven J.; Hacia, Joseph G. // Stem Cell Research & Therapy;Aug2015, Vol. 6 Issue 1, p1 

    Introduction: Zellweger spectrum disorder (PBD-ZSD) is a disease continuum caused by mutations in a subset of PEX genes required for normal peroxisome assembly and function. They highlight the importance of peroxisomes in the development and functions of the central nervous system, liver, and...

  • Stem Cell Mutations Explored. Luntz, Stephen // Australasian Science;Mar2012, Vol. 33 Issue 2, p5 

    The article discusses a research study on pluripotent stem cells which found that there are higher mutation rates in the induced pluripotent stem cell (iPS) lines as compared with the human embryonic stem (HES) cell lines.

  • Unexpected mutations put stem cell trial on hold. Coghlan, Andy // New Scientist;8/8/2015, Vol. 227 Issue 3033, p9 

    The article reports that a stem-cell trial using induced pluripotent stem cells has been halted after mutations were found in the cells of a participant, including a mutation that could carry a remote cancer risk, and mentions the trial turned skin cells into retinal cells to try and reverse...

  • The individuality of stem cells. Lander, Arthur D. // BMC Biology;2011, Vol. 9 Issue 1, p40 

    In this article the author comments on the uniqueness of stem cells. He states that stem cells are considered to be different from other cells because of properties like immortality, pluripotency and asymmetric division. However, such properties are not common in all stem cells and can be seen...

  • Neurogenic differentiation of amniotic fluid stem cells. Rosner, M.; Mikula, M.; Preitschopf, A.; Feichtinger, M.; Schipany, K.; Hengstschl√§ger, M. // Amino Acids;May2012, Vol. 42 Issue 5, p1591 

    In 2003, human amniotic fluid has been shown to contain stem cells expressing Oct-4, a marker for pluripotency. This finding initiated a rapidly growing and very promising new stem cell research field. Since then, amniotic fluid stem (AFS) cells have been demonstrated to harbour the potential to...

  • Phacomatosis Pigmentokeratotica Is a 'Pseudodidymosis'. Happle, Rudolf // Journal of Investigative Dermatology;Aug2013, Vol. 133 Issue 8, p1923 

    In phacomatosis pigmentokeratotica, papular nevus spilus coexists with nevus sebaceus. The disorder was thought to be a didymosis with early postzygotic recombination. In this issue, however, Groesser and co-workers provide a new concept. Both nevi originate from a single heterozygous HRAS...

  • Patient-Specific Naturally Gene-Reverted Induced Pluripotent Stem Cells in Recessive Dystrophic Epidermolysis Bullosa. Tolar, Jakub; McGrath, John A; Xia, Lily; Riddle, Megan J; Lees, Chris J; Eide, Cindy; Keene, Douglas R; Liu, Lu; Osborn, Mark J; Lund, Troy C; Blazar, Bruce R; Wagner, John E // Journal of Investigative Dermatology;May2014, Vol. 134 Issue 5, p1246 

    Spontaneous reversion of disease-causing mutations has been observed in some genetic disorders. In our clinical observations of severe generalized recessive dystrophic epidermolysis bullosa (RDEB), a currently incurable blistering genodermatosis caused by loss-of-function mutations in COL7A1...

  • Reduced PLP1 expression in induced pluripotent stem cells derived from a Pelizaeus-Merzbacher disease patient with a partial PLP1 duplication. Shimojima, Keiko; Inoue, Takahito; Imai, Yuki; Arai, Yasuhiro; Komoike, Yuta; Sugawara, Midori; Fujita, Takako; Ideguchi, Hiroshi; Yasumoto, Sawa; Kanno, Hitoshi; Hirose, Shinichi; Yamamoto, Toshiyuki // Journal of Human Genetics;Sep2012, Vol. 57 Issue 9, p580 

    Pelizaeus-Merzbacher disease (PMD) is an X-linked recessive disorder characterized by dysmyelination of the central nervous system (CNS). We identified a rare partial duplication of the proteolipid protein 1 gene (PLP1) in a patient with PMD. To assess the underlying effect of this duplication,...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics